June 2017 Newsletter

June 22, 2017:

US Ophthalmic Procedures Increase 10.4 Percent in Q1-2017, Boosted by Growth in IVT Injections

Retinal surgery volume rose 22.3 percent year over year.

June 22, 2017:

Mynosys Zepto Receives US FDA 510(k) Clearance

The system is the first non-laser automated cataract capsulotomy device to gain US approval.

June 22, 2017:

Component IOL Designs Increasing, Along with Customization Options

At least four companies are in various stages of developing these lenses.

June 22, 2017:

US Supreme Court Ruling Shortens Time to Market for Biosimilars

Copycat drugmakers no longer have to wait until after approval to give notice to biologic producer.

June 22, 2017:

Gottlieb Says FDA to Publish List of Drugs Without Generic Competition

Commissioner told US lawmakers that adding two generic options nearly halves cost of branded drug.

June 22, 2017:

Drug Pricing Scrutinized by AMA, Senate HELP Committee

The medical association adopted a policy calling for drugmakers to include the suggested retail prices of drugs in consumer ads.

June 22, 2017:

Carl Zeiss Meditec to Build New Innovation Center in Northern California

The proposed development would accommodate about 1,500 employees.

June 22, 2017:

TearClear Raises $4.5M in Series A to Develop Drug Filtering Technology

The filtering system is designed to deliver preservative-free drops from preserved multidose products.

June 22, 2017:

Johnson & Johnson Vision Names Jonathan Talamo Chief Medical Officer

The surgeon owned a private medical practice for almost 20 years.

June 22, 2017:

Aerie Raises $125 Million, Reports Positive Phase III Results for Roclatan

The company plans to submit a new drug application for Roclatan in the first half of 2018.

June 22, 2017:

Implandata’s EYEMATE System for Continuous IOP Monitoring Receives CE Marking

The implantable, permanent sensor measures intraocular pressure throughout the day in glaucoma patients.

June 22, 2017:

Nicox’ Zerviate Gains US Approval for Ocular Itching with Allergic Conjunctivitis

The drug’s FDA target action date was Sept. 8, 2017.

June 22, 2017:

Ellex Acquires Royalty Commitment for iTrack Device

The company agreed to pay $2.15 million for future royalties on the technology, which Ellex acquired in 2014.

June 22, 2017:

jCyte’s Cell Therapy Candidate for RP to Get Expedited Review in US; Phase IIb Underway

jCell uses retinal progenitor cells to rescue diseased retinal cells.

June 22, 2017:

Valeant in Talks to Sell Ophthalmic Surgical Business to Carl Zeiss Meditec

The division could be worth $2 billion, according to reports.

June 22, 2017:

Market Scope Weekly Polls

June 22, 2017:

STAAR’s EVO+ Visian ICL with Aspheric (EDOF) Optic Receives CE Mark Approval

The company said a trial is underway for a presbyopia-correcting version.

June 22, 2017:

Market Report: Demand for Ultrasonic Phaco Still Running Strong after 50 Years

The cataract equipment market will total $1.55 billion in 2017

June 22, 2017:

Market Report: Lasers Play Important Role in Retina, Glaucoma, Cataract Markets

Global revenues for ophthalmic lasers will total $422 million in 2017.

June 22, 2017:

Teva Launches Generic Version of Pataday in US

Novartis owns the Pataday brand, acquiring it with its purchase of Alcon.

June 22, 2017:

Roger Steinert, Pioneer in Ophthalmology, Dies at 66

His early work at Harvard helped lay the foundation for LASIK refractive surgery.

June 22, 2017:

June 2017 News Briefs

Social media